Benedikt Steitz

Title: Benedikt Steitz: Innovator in Calcium-Channel Blocking Agents

Introduction

Benedikt Steitz is a notable inventor based in Speyer, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of delivery systems for medications. His innovative approach focuses on enhancing the efficacy of calcium-channel blocking agents.

Latest Patents

Benedikt Steitz holds a patent for a "Delivery system for sustained release of a calcium-channel blocking agent." This delivery system is designed for introduction into the cerebrospinal fluid of a subject. It comprises a solid dispersion product of a calcium-channel blocking agent in a mixture of two types of poly(lactide-co-glycolide). The first poly(lactide-co-glycolide) has a specific molecular weight distribution, while the second type has a different molecular weight distribution. The molecular weights are carefully selected to ensure optimal performance, with the range being from 2000 to 3000 g/mol. This innovative system is strategically deposited near blood vessels that are experiencing or are at risk of vasospasm.

Career Highlights

Throughout his career, Benedikt Steitz has worked with various companies, including BDS Pharma GmbH and Bit Pharma GmbH. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking advancements in pharmaceutical technology.

Collaborations

Benedikt has collaborated with notable professionals in his field, including Jorg Breitenbach and Bernd Liepold. These partnerships have fostered an environment of innovation and have led to the development of effective pharmaceutical solutions.

Conclusion

Benedikt Steitz is a distinguished inventor whose work in the field of calcium-channel blocking agents has the potential to significantly impact medical treatments. His innovative delivery system exemplifies the importance of research and development in pharmaceuticals.